Identification of new markers discriminating between myeloid and lymphoid acute leukemia

References

• Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431–448.
   PubMed Web of Science ®Google Scholar
• Summers K, Stevens J, Kakkas I et al. Wilm's tumor 1 mutationsare associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia 2007; 21: 550–551.
   PubMed Web of Science ®Google Scholar
• Frohling S, Schlenk RF, Stolze I et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytoge-netics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004; 22: 624–633.
   PubMed Web of Science ®Google Scholar
• Thielde C, Koch S, Creutzig E et al. Prevalence and prognostic impact of NPM1 mutations in 1,485 adult patients with acute myeloid leukemia (AML). Blood 2006; 107: 4011–4020.
   PubMed Web of Science ®Google Scholar
• Baldus CD, Thiede C, Soucek S, Bloomfield CD, Thiel E, Ehninger G. BAALC and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics; prog-nostic implications. J Clin Oncol 2006; 24: 790–797.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Maharry K, Whitman SP et al. High expression levels of ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Gun Oncol 2007; 25: 3337–3343.
   Web of Science ®Google Scholar
• Heuser M, Beutel G, Krauter J et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 2006; 108: 3898–3905.
   PubMed Web of Science ®Google Scholar
• Dohner K, Tobis K, Ulrich R et al. Prognostic significance of partial tandem duplication of the MLL gene in adult patients 16 and 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002; 20: 3254–3261.
   PubMed Web of Science ®Google Scholar
• Bennet JM, Catovsky D, Daniel MT et al. Proposed revised criteriafor the classification of acute myeloid leukemia. A report of the French—American—British Cooperative Group. Ann Intern Med 1985; 103: 620–625.
   PubMed Web of Science ®Google Scholar
• Vladimir JW, Harris NL, Brunning RD. The World Health Organisation (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.
   PubMed Web of Science ®Google Scholar
• Golub T, Slonim D, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531–537.
   PubMed Web of Science ®Google Scholar
• Valk P, Verhaak R, Beijen M et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617–1628.
   PubMed Web of Science ®Google Scholar
• Haferlach T, Kohlmann A, Schnittger S et al. A global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005; 106: 1189–1198.
   PubMed Web of Science ®Google Scholar
• Bullinger L, Dohner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605–1616.
   PubMed Web of Science ®Google Scholar
• Wilson CS, Davidson GS, Martin SB et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 2006; 108: 685–696.
   PubMed Web of Science ®Google Scholar
• Court EL, Smith MA, Avent ND et al. Microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leukemia Res 2004; 28: 743–753.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Haferlach T. Gene expression profiling in acute myeloid leukemia. N Engl J Med 2004; 350: 1676–1678.
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207–210.
   PubMed Web of Science ®Google Scholar
• Rhodes D, Yu J, Shanker K et al. ONCOMINE: a cancer microarray database and data-mining platform. Neoplasia 2004; 6: 1–6.
   PubMed Web of Science ®Google Scholar
• Parkinson H, Sarkans U, Shojatalab M et al. ArrayExpress — a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2005; 33( Database issue): D553—D555.
   PubMed Web of Science ®Google Scholar
• Larkin J, Frank B, Gavras H, Sultana R, Quackenbush J. Independence and reproducibility across microarray platforms. Nat Methods 2005; 2: 337–344.
   PubMed Web of Science ®Google Scholar
• Bammler T, Beyer R, Bhattacharya S et al. Standardizing global gene expression analysis between laboratories and across plat-forms. Nat Methods 2005; 2: 351–356.
   PubMed Web of Science ®Google Scholar
• Irizarry R, Warren D, Spencer F et al. Multiple laboratory comparison of microarray platforms. Nat Methods 2005; 2: 345–350.
   PubMed Web of Science ®Google Scholar
• Staal FJT, Cario G, Cazzaniga G et al. Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia 2006; 20: 1385–1392.
   PubMed Web of Science ®Google Scholar
• Thomas JG, Olson JM, Tapscott Si, Zhao LP. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 2001; 11: 1227–1236.
   PubMed Web of Science ®Google Scholar
• Nilsson B, Andersson A, Johanson M, Fioretos A. Cross-platform classification in microarray-based leukemia diagnosis. Haematologica 2006; 91: 821–824.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate—phenol—chloroform extraction. Anal Biochem 1987; 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Tusher VG, Tibbshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121.
   PubMed Web of Science ®Google Scholar
• Koerner HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogen-ous leukemia cell line (KG-1). Blood 1980; 56: 265–273.
   PubMed Web of Science ®Google Scholar
• Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233–1235.
   PubMed Web of Science ®Google Scholar
• Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080–1086.
   PubMed Web of Science ®Google Scholar
• Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45: 321–334.
   PubMed Web of Science ®Google Scholar